Phlebotomy Equipment Market Size, Share, and COVID-19 Impact Analysis, By Product (Needles and Syringes, Blood Collection Tubes, Blood Bags, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Others), and by Regional Forecast, 2025-2032

Phlebotomy is also known as a blood draw or venipuncture. It is performed for diagnostic or therapeutic purposes, by a phlebotomist, in which specific laboratory equipment is required. Also, there are specific guidelines for carrying out these procedures. Phlebotomy equipment is used for blood sampling and collection in diagnostic procedures to detect acute and chronic disorders. The rising cases of various diseases and accidents are primarily driving the market growth.

Furthermore, the increasing number of blood donations and transfusions is favoring market growth. According to an article published by World Health Organization (WHO) in 2022, approximately 13,300 blood centers in 169 countries collected 106 million blood donations. Recent technological advancements coupled with strategic initiatives by prominent key players for blood collection drive the market growth during the forecast period.

Despite of robust blood collection procedures, the lack of skilled healthcare professionals, especially in emerging nations, restricts market growth.

Impact of COVID-19 on the Phlebotomy Equipment Market

The outbreak of the COVID-19 pandemic had a positive impact on the global market. There was a surge in the number of blood testing procedures due to the pandemic, where blood samples were used to diagnose infectious diseases such as COVID-19. According to an article published in the Times of India in 2021, a study from the journal 'Blood Advances' states that blood tests can offer an early indicator of severe COVID-19.

Despite of COVID-19 pandemic disruption in business activities, the key players in the market had reported a rise in their annual revenue. This is owing to the rising initiatives by key players to launch various advanced blood collection products in the market. For instance, major players, such as BD (Becton, Dickinson, and Company), witnessed a rise of 8.7% in 2020 compared to 2019. Also, the company witnessed a sustainable growth of 39.7% in 2021 compared to 2020.

Key Insights

• Prevalence of Blood Disorders, By Key Countries, 2022.
• Number of Blood Donations, By Key Countries, 2022.
• Key Industry Developments – Mergers, Acquisitions, and Partnerships.
• New Product Launches, By Key Players.
• Impact of COVID-19 on the Phlebotomy Equipment Market.

Analysis by Product:

Based on the product, the global phlebotomy equipment market is segmented into needles and syringes, blood collection tubes, blood bags, and others. The needles and syringes are expected to hold the largest share in 2021. The surge in the usage of needles and syringes to draw blood for therapeutic and diagnostic applications is contributing to the market’s growth. Also, rising technological advancements in phlebotomy equipment such as robotic needle insertion augment the market expansion. For instance, in May 2022, Vitestro announced that the first fully autonomous blood-sampling robot would be launched in European hospitals and outpatient clinics by 2024. It is a blood-sampling robot with artificial intelligence, ultrasound-guided 3D reconstruction, and robotic needle insertion. Such factors fuel the market growth.

Regional Analysis:

To gain extensive insights into the market, Download for Customization

North America held a significant market share in 2022 due to the strong presence of major companies and the robust adoption of advanced phlebotomy equipment. Also, rising initiatives by various key players to train healthcare professionals to serve better propelling regional growth. In August 2022, MAKO Medical Laboratories gained the company’s accreditation as an American Society of Phlebotomy Technicians (ASPT) training school for phlebotomists. It has also launched a training program effective immediately for MAKO team members.

Key Players Covered

The report will include the profiles of key players such as Marketlab, Cardinal Health, SB-Kawasumi Laboratories, Inc., Heathrow Scientific, BD (Becton, Dickinson and Company), Medtronic, Nipro Medical Corporation, and others.

Segmentation

Key Industry Developments

• May 2022: Babson Diagnostics partnered with BD (Becton, Dickinson and Company) to move blood sample collection into new care settings. Also, they enabled the patients to collect blood samples at home for diagnostic testing.
• January 2022: MediBuddy launched its Phlebotomy team. The company plans to expand comprehensive healthcare services across 100 cities in India.
• July 2021: BD (Becton, Dickinson and Company) acquired Velano Vascular to expand its product portfolio with innovative needle-free blood draw technology to reduce the pain and discomfort of multiple needle sticks.